Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
After weight loss with ZEPBOUND treatment during the open-label lead-in period (Week 0 to Week 36), continued treatment with ZEPBOUND from randomization (Week 36) to Week 88 resulted in a statistically significant reduction in body weight compared with placebo (see Table 6)
Tirzepatide produced even higher results in some studies
Obesidad y sobrepeso
The company positions it for consumers seeking non-prescription, non-pill, non-injection options
No, it is essential to use designated areas like the abdomen, thigh, or upper arm to ensure proper absorption and reduce the risk of complications
S.WangS
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
